MAD2L1 and squamous cell lung carcinoma: The expression profile of NDC80 and MAD2L1 was analyzed in various tumors using GEPIA and we discovered that both NDC80 and MAD2L1 were broad-spectrum up-regulated in multiple human tumors including lung adenocarcinoma and lung squamous cell carcinoma (Fig. 6a, f).